Precision BioSciences

$9.65
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (+0.84%) Today
+$0.07 (+0.73%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell DTIL and other stocks, options, ETFs, and crypto commission-free!

About DTIL

Precision BioSciences, Inc. Common Stock, also called Precision BioSciences, is a biotechnology company, which engages in the development of genome editing technologies. Read More It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and of novel products outside immuno-oncology to treat human diseases. The Food segment applies ARCUS, the company's propriety genome editing platform, to develop food and nutrition products through collaboration agreements with consumer-facing companies. The company was founded by Derek N. Jantz, Jeff Smith, and Matthew R. Kane in January 2006 and is headquartered in Durham, NC.

Employees
127
Headquarters
Durham, North Carolina
Founded
2006
Market Cap
482.48M
Price-Earnings Ratio
Dividend Yield
Average Volume
2.32M
High Today
$10.25
Low Today
$9.52
Open Price
$10.13
Volume
3.63M
52 Week High
$23.67
52 Week Low
$6.24

Collections

DTIL News

MarketWatchDec 9

Precision BioSciences stock rises on early-stage CAR-T trial data

Shares of Precision BioSciences Inc. DTIL, +6.21% are up 13% in premarket trading after it announced positive results from a small Phase 1 clinical trial for it
1,508

DTIL Earnings

-$1.99
-$1.46
-$0.92
-$0.39
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
Actual
Expected Mar 26, Pre-Market

You May Also Like

Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.
Search
LearnBlogCareersHelpLog InSign Up